查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995559

外科縫合線市場：按材料、生物分解性、線材、應用和最終用戶分類－2026-2032年全球市場預測

Surgical Suture Market by Material, Biodegradability, Filament, Application, End-user - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科縫線市場價值將達到 53.8 億美元，到 2026 年將成長至 56.9 億美元，到 2032 年將達到 79.8 億美元，複合年成長率為 5.80%。

主要市場統計數據
基準年 2025 53.8億美元
預計年份：2026年 56.9億美元
預測年份 2032 79.8億美元
複合年成長率 (%) 5.80%

為全面探索影響全球醫療保健的外科縫合創新和市場動態奠定基礎。

外科縫合線市場在改善全球醫療效果方面發揮著至關重要的作用，其傷口縫合技術能夠影響癒合過程和病人安全。縫合線是外科手術的基本組成部分，它提供機械支撐，同時最大限度地降低感染風險，並促進最佳的組織再生。隨著手術日益複雜和患者群體老化，對創新縫合解決方案的需求持續成長。

揭示了重新定義整個醫療保健生態系統中外科縫合線市場格局的關鍵技術、監管和臨床進步。

在技​​術快速突破、法規結構不斷改進以及臨床實踐不斷改變的推動下，外科縫合線行業正經歷著一場意義深遠的變革時期。生物活性塗層、藥物釋放型絲和新一代可吸收聚合物等創新技術正在重新定義有效傷口縫合的標準。因此，製造商正大力投資研發，力求將抗菌特性和緩釋藥物直接融入縫線基質中，進而減少術後併發症，加速患者復原。

評估將於 2025 年實施的美國新關稅對供應鏈、定價結構和產業競爭力的廣泛影響。

美國將於2025年實施的新關稅為依賴進口原料和成品縫合線的企業帶來了巨大的成本挑戰。特別是，特種聚合物和鈷基針合金關稅的提高波及整個供應鏈，迫使製造商重新評估其籌資策略。因此，許多企業正在探索建立本地生產夥伴關係關係，以降低進口成本並維持價格競爭力。

闡明材料成分、生物分解性、絲狀結構、臨床應用和終端用戶環境等方面的關鍵見解，以指南市場策略。

從材料成分的角度分析市場，可以發現天然縫合線和合成縫合線在性能方面有差異。天然纖維具有良好的生物相容性，特別適用於精細手術；而合成聚合物則提供穩定的拉伸強度和可預測的吸收率。因此，選擇哪一類縫合線取決於手術需求和外科醫生的個人偏好。

本報告詳細分析了美洲、歐洲、中東和非洲以及亞太地區的市場趨勢和成長要素，揭示了每個地區獨特的市場動態和戰略挑戰。

不同地區對外科縫合線的需求差異，是由各地區獨特的醫療基礎設施、法規環境和創新生態系統所決定的。在美洲，完善的健保報銷體系、成熟的醫院網路和強大的本土製造能力，推動了先進縫線技術的持續應用。此外，積極的公私合作研究舉措也增強了產品平臺，並加速了臨床檢驗。

分析領先的外科縫合線製造商及其策略聯盟，這些聯盟推動了動態醫療保健市場的創新、擴充性和競爭差異化。

外科縫合線領域的主要企業正利用對研發的策略投資來建立競爭優勢。成熟的醫療設備集團透過收購專注於可吸收聚合物和抗菌塗層等利基生物技術創新企業，拓展了產品組合。因此，它們擁有豐富的產品線，能夠滿足各種臨床需求和價格範圍。

為推動創新管道實現永續成長、增強供應鏈韌性以及改善臨床夥伴關係模式提出策略建議。

產業領導企業應優先考慮整合兼具機械強度、抗菌性能和藥物遞送能力的多功能生物材料。投資於模組化研發框架將加速產品迭代改進，並支援在不斷變化的監管標準下進行快速測試。此外，與臨床研究機構建立夥伴關係將有助於在真實手術環境中儘早檢驗新一代絲材的表現。

詳細介紹了綜合性的多階段調查方法，該方法結合了二手分析、專家訪談和資料三角驗證，以確保分析的嚴謹性。

本分析基於嚴謹的多階段調查方法，旨在確保數據的可靠性並全面覆蓋外科縫合線市場。首先，我們進行了廣泛的二手資料研究，重點關注同行評審期刊、監管文件和行業出版物，以深入了解技術趨勢、材料科學進展和政策發展。

總結關鍵發現和策略意義，為相關人員提供外科縫線投資、開發和競爭差異化的明確指南。

總之，外科縫線市場正處於一個關鍵的轉折點，技術創新、不斷變化的監管環境和供應鏈重組的交織正在重塑競爭格局。儘管材料和多功能絲材設計的進步開闢了新的臨床應用前景，但關稅的引入凸顯了多元化採購和區域化生產策略的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科縫合線市場：依材料分類

  • 自然的
  • 合成

第9章 外科縫合線市場：生物分解性

  • 吸收性
  • 不吸收

第10章：按絲材類型分類的外科縫合線市場

  • 單絲
  • 多絲纖維

第11章 外科縫線市場：依應用領域分類

  • 心臟外科手術
    • 冠狀動脈繞道手術手術（CABG）
    • 心臟瓣膜修復/置換術
  • 一般外科
  • 神經外科
  • 眼科手術
    • 白內障手術
    • 角膜移植
  • 整形外科
    • 關節鏡手術
    • 骨折固定和韌帶修復
    • 關節重建手術
  • 整形和重組外科
    • 乳房重建
    • 美容護理

第12章 外科縫合線市場：依最終用戶分類

  • 門診手術中心（ASC）
  • 診所
  • 醫院
  • 研究和學術機構

第13章 外科縫合線市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 外科縫合線市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 外科縫合線市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國外科縫合線市場

第17章：中國外科縫線市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Able Medical Devices Inc.
  • AD Surgical
  • Advanced Medical Solutions Group plc
  • AIP Medical SA
  • Atramat by Internacional Farmaceutica SA . de CV
  • B. Braun SE
  • Centenial Surgical Suture Ltd.
  • CONMED Corporation
  • Corza Medical GmbH
  • DemeTECH Corporation
  • Demophorius Healthcare Ltd.
  • Dolphin Sutures
  • Genesis Medtech
  • GMD Group
  • Healthium Medtech Ltd.
  • Johnson & Johnson Services, Inc.
  • Lotus Surgicals Pvt Ltd
  • Lux Sutures SA
  • Lydus Medical
  • McKesson Medical-Surgical Inc.
  • Medtronic PLC
  • Mellon Medical BV
  • Orion Sutures India Pvt Ltd
  • Riverpoint Medical
  • Shandong Haidike Medical Products Co.,Ltd.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Sutumed Corp.
  • SUTUREGARD Medical, Inc.
  • Teleflex Incorporated
  • Unisur Lifecare Pvt. Ltd.
  • Vitrex Medical A/S
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-FD3F12D52777

The Surgical Suture Market was valued at USD 5.38 billion in 2025 and is projected to grow to USD 5.69 billion in 2026, with a CAGR of 5.80%, reaching USD 7.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.38 billion
Estimated Year [2026] USD 5.69 billion
Forecast Year [2032] USD 7.98 billion
CAGR (%) 5.80%

Setting the Stage for a Comprehensive Exploration of Surgical Suture Innovations and Market Dynamics Impacting Global Healthcare

The surgical suture market plays a pivotal role in advancing global healthcare outcomes through wound closure techniques that influence healing trajectories and patient safety. Sutures form a foundational component of surgical practice, providing mechanical support while minimizing infection risk and promoting optimal tissue regeneration. As procedures grow increasingly complex and patient populations age, the demand for innovative suture solutions continues to intensify.

This executive summary delivers a comprehensive overview of the key trends, regulatory shifts, and competitive dynamics shaping the surgical suture landscape. It synthesizes insights across material innovations, biodegradability considerations, filament technologies, application domains, and end-user channels to guide decision-makers in aligning their strategies with emerging market realities. Furthermore, it examines the implications of recent policy changes, including the introduction of new tariffs, which are poised to influence cost structures and supply chain resilience.

Drawing upon expert interviews, secondary research, and rigorous data validation, this summary offers a concise yet thorough narrative designed to inform stakeholders in device manufacturing, clinical practice, investment, and policy development. By navigating through transformative shifts, segmentation analyses, regional nuances, and competitive positioning, readers will gain an integrated perspective to drive informed action and sustained growth in the surgical suture sector.

Unveiling the Pivotal Technological, Regulatory, and Clinical Advancements Redefining the Surgical Suture Market Landscape Across the Healthcare Ecosystem

The surgical suture industry is undergoing a period of profound transformation driven by rapid technological breakthroughs, evolving regulatory frameworks, and shifting clinical practices. Innovations such as bioactive coatings, drug-eluting filaments, and next-generation absorbable polymers are redefining the parameters of wound closure efficacy. Consequently, manufacturers are investing heavily in research to integrate antimicrobial properties and controlled-release therapeutics directly into suture matrices, thereby reducing postoperative complications and expediting patient recovery.

Simultaneously, regulatory bodies are tightening quality and safety standards, mandating enhanced traceability and rigorous performance testing. This trend has accelerated the adoption of digital tracking systems and advanced sterilization protocols, ensuring that sutures meet the stringent demands of global healthcare providers. Moreover, the rise of minimally invasive and robotic-assisted surgical techniques has heightened the need for precision-engineered filaments capable of navigating delicate anatomical structures.

In parallel, sustainability considerations have prompted a shift toward eco-friendly materials that address the environmental impact of synthetic polymers. Biodegradable options are gaining traction among clinicians seeking to balance performance with ecological responsibility. As a result, the confluence of clinical, regulatory, and environmental drivers is setting new benchmarks for product development, compelling industry participants to adapt swiftly or risk obsolescence.

Assessing the Far-Reaching Effects of Newly Implemented United States Tariffs in 2025 on Supply Chains, Pricing Structures, and Industry Competitiveness

The implementation of new United States tariffs in 2025 has introduced significant cost challenges for companies reliant on imported raw materials and finished suture products. In particular, higher duties on specialized polymers and cobalt-based needle alloys have reverberated through supply chains, prompting manufacturers to reassess their sourcing strategies. As a result, many organizations are exploring localized production partnerships to mitigate import expenses and maintain competitive pricing structures.

Moreover, distributors and healthcare providers have felt the impact through elevated procurement costs, which have necessitated renegotiations of supply contracts and spurred interest in alternative filament technologies that are exempt from the newest tariff classifications. Consequently, synthetic polymer suppliers within the U.S. have seen heightened demand, leveraging their domestic footprint to offer expedited fulfillment and reduced duty burdens.

However, this recalibration has not been without its trade-offs. Transitioning to alternative suppliers often entails extended lead times and additional validation processes, introducing potential risks to inventory continuity. To that end, industry participants are investing in dual-sourcing models and strategic stockpiling to safeguard against supply disruptions. In sum, the 2025 tariff adjustments have accentuated the importance of supply chain agility and cost management as critical success factors in the surgical suture market.

Illuminating Critical Insights Across Material Composition, Biodegradability Profiles, Filament Architectures, Clinical Applications, and End-User Environments to Guide Market Strategies

Analyzing the market through the lens of material composition reveals divergent performance profiles between natural and synthetic sutures. Natural fibers offer biocompatibility advantages, particularly in delicate procedures, whereas synthetic polymers deliver consistent tensile strength and predictable absorption rates. Consequently, the choice between these two categories hinges on procedural requirements and surgeon preferences.

Turning to biodegradability, absorbable sutures have gained prominence in scenarios where secondary removal procedures pose additional risk, while non-absorbable filaments persist in applications demanding prolonged mechanical support, such as cardiovascular anastomoses. This distinction shapes product development priorities and inventory management protocols across healthcare institutions.

Examining filament structure, monofilament designs minimize tissue drag and reduce infection risk, making them preferable for skin closures and urologic repairs. In contrast, multifilament constructs enhance knot security and pliability, which supports their adoption in gastrointestinal and orthopedic surgeries. The interplay between filament type and clinical context informs surgeon selection and procurement strategies.

When considering the application spectrum, sutures tailored for cardiac surgery must accommodate coronary artery bypass grafting and heart valve repair with precision, while ophthalmic options address cataract surgery and corneal transplantation through ultra-fine gauge materials. Orthopedic use cases range from arthroscopy to fracture fixation and joint replacement, demanding robust tensile performance. Plastic and reconstructive procedures, encompassing breast reconstruction and cosmetic enhancements, prioritize both structural integrity and aesthetic outcomes.

Finally, end-user dynamics span ambulatory surgical centers seeking cost-effective, streamlined solutions; clinics requiring ready-to-use kits; hospitals demanding broad product portfolios; and research and academic institutes focused on experimental biomaterials. This multifaceted segmentation underscores the necessity for customized offerings that align with the distinct priorities of each customer group.

Dissecting Regional Performance and Growth Drivers Within the Americas, Europe Middle East & Africa, and Asia Pacific to Reveal Unique Market Dynamics and Strategic Imperatives

Regional variations in surgical suture demand are shaped by distinct healthcare infrastructures, regulatory environments, and innovation ecosystems. Within the Americas, strong reimbursement frameworks, established hospital networks, and robust domestic manufacturing capabilities drive sustained adoption of advanced suture technologies. Furthermore, proactive public-private collaborations in research initiatives bolster product pipelines and accelerate clinical validation.

In contrast, Europe, Middle East & Africa presents a mosaic of regulatory standards and procurement practices. While Western European markets prioritize high-performance, bioactive sutures supported by extensive clinical data, emerging markets in the Middle East and Africa are increasingly investing in capacity-building to meet rising surgical volumes. Collaborative efforts to harmonize standards and streamline approval processes are elevating regional competitiveness.

Meanwhile, the Asia-Pacific region has emerged as a powerhouse for both production and consumption. Rapid healthcare modernization, growing surgical volumes, and expanding medical tourism have fueled demand for cost-effective yet innovative suture solutions. Local manufacturers are scaling up capabilities to supply both domestic and export markets, while multinational corporations forge partnerships to navigate diverse regulatory frameworks and leverage distribution networks.

Together, these regional insights highlight the importance of tailoring market entry and growth strategies to align with localized regulatory landscapes, clinical practices, and supply chain considerations. By recognizing the nuanced drivers within each geography, companies can optimize product positioning and resource allocation to capture emerging opportunities.

Profiling Leading Surgical Suture Manufacturers and Their Strategic Collaborations Fueling Innovation, Scalability, and Competitive Differentiation in a Dynamic Healthcare Market

Leading participants in the surgical suture domain have leveraged strategic investments in research and development to establish competitive moats. Established medical device conglomerates have expanded their portfolios through targeted acquisitions of niche biotech innovators specializing in absorbable polymers and antimicrobial coatings. As a result, they maintain a broad product range that addresses diverse clinical requirements and price points.

At the same time, specialized manufacturers have distinguished themselves by focusing on next-generation biomaterials, such as bioresorbable copolymers and drug-infused filaments, enabling them to capture share in high-growth segments. Through collaborations with academic research centers, these companies benefit from early access to experimental data and can accelerate product commercialization timelines.

Distribution partners have also played a pivotal role by integrating digital procurement platforms, which provide real-time visibility into stock levels, usage trends, and performance outcomes. These systems enhance decision support for healthcare providers and reinforce supplier relationships.

Additionally, alliances between device producers and contract manufacturing organizations have streamlined scale-up processes, reducing time to market for innovative offerings. By combining technological expertise with manufacturing agility, these partnerships enable rapid response to shifting clinical demands and emerging tariff constraints.

Overall, the market's competitive landscape is defined by the interplay between legacy manufacturers, agile niche players, and value-added distributors, each contributing to a dynamic environment of continuous innovation and strategic repositioning.

Delivering Strategic Recommendations to Drive Innovation Pipelines, Strengthen Supply Chain Resilience, and Enhance Clinical Partnership Models for Sustainable Growth

Industry leaders should prioritize the integration of multifunctional biomaterials that combine mechanical strength with antimicrobial and drug-delivery capabilities. Investing in modular R&D frameworks will accelerate iterative product enhancements and support rapid testing under evolving regulatory standards. Moreover, cultivating partnerships with clinical research institutions can facilitate early validation of next-generation filaments in real-world surgical settings.

In light of supply chain uncertainties accentuated by new tariffs, organizations must develop dual-sourcing strategies and evaluate regional manufacturing alliances to secure material access and mitigate cost volatility. Establishing strategic stock reserves and leveraging contract manufacturing relationships will enhance agility and maintain continuity of supply.

Furthermore, enhancing digital engagement with healthcare providers through integrated procurement and performance-tracking platforms will yield actionable usage data. This intelligence can inform targeted marketing efforts, optimize product mix, and strengthen customer loyalty by demonstrating clinical value in quantifiable terms.

To capture emerging opportunities in high-growth applications, firms should tailor their portfolio to address specialized procedures such as robotic-assisted minimally invasive surgeries and reconstructive interventions. Customizing suture solutions for these niches will position companies as preferred partners for advanced surgical care.

Finally, embedding sustainability targets into product development roadmaps-by reducing environmental impact of polymers and packaging-will align with global healthcare sustainability mandates and resonate with environmentally conscious stakeholders.

Detailing a Comprehensive Multistage Research Methodology Blending Secondary Analysis, Expert Interviews, and Data Triangulation to Ensure Analytical Rigor

This analysis is grounded in a rigorous, multistage research methodology designed to ensure data reliability and comprehensive coverage of the surgical suture market. Initially, an extensive secondary review of peer-reviewed journals, regulatory filings, and industry publications established baseline understanding of technological trends, material science advances, and policy developments.

Subsequently, primary interviews were conducted with a cross-section of stakeholders, including senior executives from leading medical device manufacturers, procurement leaders at major healthcare systems, and key opinion leaders specializing in surgical practice. These in-depth conversations provided nuanced perspectives on clinical requirements, unmet needs, and adoption barriers.

Quantitative data was triangulated through data validation protocols, comparing trade statistics, patent filings, and public financial disclosures to ensure consistency and accuracy. Advanced analytical models were then applied to identify correlations between segmentation variables and market dynamics.

Throughout the research process, iterative quality checks and peer reviews were implemented to uphold methodological rigor. This robust approach combines qualitative insights with empirical evidence, furnishing a solid foundation for the strategic findings and recommendations presented in this summary.

Summarizing Core Findings and Strategic Implications to Empower Stakeholders With Clear Directions for Investment, Development, and Competitive Differentiation in Surgical Sutures

In conclusion, the surgical suture market stands at a critical inflection point where technological innovation, regulatory evolution, and supply chain realignment converge to redefine competitive landscapes. Material advancements and multifunctional filament designs are unlocking new clinical possibilities, while the introduction of tariffs has underscored the necessity of diversified sourcing and regional manufacturing strategies.

Segmentation insights reveal that customizing suture solutions across material types, biodegradability profiles, filament structures, application areas, and end-user channels is paramount to meeting diverse clinical demands. Regional intelligence highlights that strategic market entries must consider localized regulatory requirements and distribution paradigms to maximize impact.

Key players are forging strategic alliances, investing in digital procurement platforms, and expanding their portfolios through targeted acquisitions to maintain market leadership. Industry stakeholders must respond by aligning innovation roadmaps with emerging procedural trends, reinforcing supply chain flexibility, and embedding sustainability into their core strategies.

By synthesizing these insights and recommendations, decision-makers are equipped with a clear blueprint to navigate the unfolding opportunities and challenges of the surgical suture arena, driving sustained value creation and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Suture Market, by Material

  • 8.1. Natural
  • 8.2. Synthetic

9. Surgical Suture Market, by Biodegradability

  • 9.1. Absorbable
  • 9.2. Non Absorbable

10. Surgical Suture Market, by Filament

  • 10.1. Monofilament
  • 10.2. Multifilament

11. Surgical Suture Market, by Application

  • 11.1. Cardiac Surgery
    • 11.1.1. Coronary Artery Bypass Grafting (CABG)
    • 11.1.2. Heart Valve Repair/Replacement
  • 11.2. General Surgery
  • 11.3. Neurological Surgery
  • 11.4. Ophthalmic Surgery
    • 11.4.1. Cataract Surgery
    • 11.4.2. Corneal Transplantation
  • 11.5. Orthopedic Surgery
    • 11.5.1. Arthroscopy
    • 11.5.2. Fracture Fixation & Ligament Repair
    • 11.5.3. Joint Replacement
  • 11.6. Plastic & Reconstructive Surgery
    • 11.6.1. Breast Reconstruction
    • 11.6.2. Cosmetic Procedures

12. Surgical Suture Market, by End-user

  • 12.1. Ambulatory Surgical Centers (ASCs)
  • 12.2. Clinics
  • 12.3. Hospitals
  • 12.4. Research & Academic Institutes

13. Surgical Suture Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Suture Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Suture Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Surgical Suture Market

17. China Surgical Suture Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Able Medical Devices Inc.
  • 18.6. AD Surgical
  • 18.7. Advanced Medical Solutions Group plc
  • 18.8. AIP Medical SA
  • 18.9. Atramat by Internacional Farmaceutica S.A . de C.V.
  • 18.10. B. Braun SE
  • 18.11. Centenial Surgical Suture Ltd.
  • 18.12. CONMED Corporation
  • 18.13. Corza Medical GmbH
  • 18.14. DemeTECH Corporation
  • 18.15. Demophorius Healthcare Ltd.
  • 18.16. Dolphin Sutures
  • 18.17. Genesis Medtech
  • 18.18. GMD Group
  • 18.19. Healthium Medtech Ltd.
  • 18.20. Johnson & Johnson Services, Inc.
  • 18.21. Lotus Surgicals Pvt Ltd
  • 18.22. Lux Sutures SA
  • 18.23. Lydus Medical
  • 18.24. McKesson Medical-Surgical Inc.
  • 18.25. Medtronic PLC
  • 18.26. Mellon Medical B.V.
  • 18.27. Orion Sutures India Pvt Ltd
  • 18.28. Riverpoint Medical
  • 18.29. Shandong Haidike Medical Products Co.,Ltd.
  • 18.30. Smith & Nephew PLC
  • 18.31. Stryker Corporation
  • 18.32. Sutumed Corp.
  • 18.33. SUTUREGARD Medical, Inc.
  • 18.34. Teleflex Incorporated
  • 18.35. Unisur Lifecare Pvt. Ltd.
  • 18.36. Vitrex Medical A/S
  • 18.37. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL SUTURE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL SUTURE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS SURGICAL SUTURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. GCC SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. G7 SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 212. G7 SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 216. G7 SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 221. NATO SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 222. NATO SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 226. NATO SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA SURGICAL SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)